首页 | 本学科首页   官方微博 | 高级检索  
     

vUTAL3CP1重组载体疫苗与pVIRIL18P1 DNA疫苗在猪体内的免疫原性研究
引用本文:金宁一,郑敏,秦晓冰,金扩世,刘棋,马鸣潇,田明尧,李昌,万遂如. vUTAL3CP1重组载体疫苗与pVIRIL18P1 DNA疫苗在猪体内的免疫原性研究[J]. 免疫学杂志, 2006, 22(3): 260-264,268
作者姓名:金宁一  郑敏  秦晓冰  金扩世  刘棋  马鸣潇  田明尧  李昌  万遂如
作者单位:军事医学科学院军事兽医研究所,长春,130062;军事医学科学院军事兽医研究所,长春,130062;广西区兽医防疫检疫站,南宁,530001;广西区兽医防疫检疫站,南宁,530001
基金项目:国家科技攻关项目;吉林省科技厅科研项目
摘    要:目的 评价本课题组构建的共表达FMDV衣壳蛋白前体P1-2A基因以及免疫辅助基因的重组鸡痘病毒vUTAL3CP1和重组DNA疫苗pVIRIL18P1在猪体内诱导特异性体液免疫和细胞免疫的能力。方法将上述2种疫苗采用4种不同的组合方式单独或联合给猪进行肌肉注射,用ELISA方法和中和实验检测猪产生的抗体水平,T淋巴细胞增殖反应、CTL反应以及T淋巴细胞亚类。结果这2种基因工程疫苗均能诱导猪产生特异性的体液及细胞免疫应答。其中单独免疫组vUTAL3CP1/vUTAL3CP1的效果最好,其诱导的抗体水平已接近于常规灭活疫苗,而细胞免疫水平则比后者高得多。联合免疫组中vUTAL3CP1/pVIRIL18P1可以诱导比vUTAL3CP1,vUTAL3CP1更高的CTL杀伤活性,但体液免疫水平略低。结论证实了这2种基因工程疫苗在猪体内均有良好的免疫原性。同时初步筛选出vUTAL3CP1/vUTAL3CP1和pVIRIL18P1/vUTAL3CP1组等较佳的免疫策略,为下一步的攻毒保护试验奠定了基础。

关 键 词:口蹄疫病毒  重组鸡痘病毒  DNA疫苗  免疫原性
文章编号:1000-8861(2006)03-0260-06
收稿时间:2005-01-04
修稿时间:2006-03-31

Immunogenicity of recombinant fowl-pox virus and DNA vaccine co-expressing foot-and-mouth disease virus P1-2A gene and pig IL-18 gene in pigs
JIN Ning-yi,ZHENG Min,QIN Xiao-bin,JIN Kuo-shi,LIU Qi,MA Ming-xiao,TIAN Ming-yao,LI Chang,WAN Sui-ru. Immunogenicity of recombinant fowl-pox virus and DNA vaccine co-expressing foot-and-mouth disease virus P1-2A gene and pig IL-18 gene in pigs[J]. Immunological Journal, 2006, 22(3): 260-264,268
Authors:JIN Ning-yi  ZHENG Min  QIN Xiao-bin  JIN Kuo-shi  LIU Qi  MA Ming-xiao  TIAN Ming-yao  LI Chang  WAN Sui-ru
Abstract:Objective To evaluate the immunogenicity of recombinant fowl-pox virus vUTAL3CP1 co-expressing P1-2A gene and 3C~(pro) gene of foot-and-mouth disease virus(FMDV) and DNA vaccine plasmid pVIRIL18P1 co-expressing P1-2A gene and pig IL-18 gene in pigs.Methods Pigs were inoculated intramuscularly with these 2 recombinant vaccines alone or in combination.The FMDV antibody were detected by ELISA and NT.T lymphoproliferation test,cytotoxic T lymphocyte response test,and T lymphocyte subpopulation were performed.Results Specific humoral and cellular immune responses could be induced in all recombinant vaccines inoculated groups.The vUTAL3CP1/vUTAL3CP1 group had higher immunogenicity in 2 single immunizing groups.Comparing with inactivated vaccine,vUTAL3CP1/vUTAL3CP1 could induce the same FMDV antibody level and higher cellular immune responses in pigs.pVIRIL18P1/vUTAL3CP1 could induce higher CTL responses but lower antibody responses compared with vUTAL3CP1/vUTAL3CP1.Conclusion Both these 2 recombinant vaccines have good immunogenicity in pigs.The results suggest that vUTAL3CP1/vUTAL3CP1 and pVIRIL18P1/vUTAL3CP1 may be the most optimal vaccination strategies,which provides a support for further virus challenge tests.
Keywords:Foot-and-mouth disease virus   Recombinant fowl-pox viruses   DNA vaccine   Immunogenicity
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号